The elusive gold standard. Future perspectives for HIV adherence assessment and intervention
- PMID: 17133199
- DOI: 10.1097/01.qai.0000243112.91293.26
The elusive gold standard. Future perspectives for HIV adherence assessment and intervention
Abstract
There is no "gold standard" for the assessment of adherence to HIV/AIDS medications. Similarly, there is no single optimal tool that enhances adherence to HIV/AIDS treatment regimens. This article presents a model that provides a heuristic for selecting adherence assessment approaches and intervention strategies based on the purpose for which each is to be used. First, a broad distinction is made between research and clinical settings. Second, with each of these settings, the selection of assessments and interventions is based on the extent to which the focus is on HIV/AIDS in general or on adherence in particular. Examples applying the model are provided. Finally, new dimensions are discussed for expanding the model, with particular attention to applying the model to the resource-limited settings that are so important in efforts to reduce the morbidity and mortality associated with the global threat of HIV/AIDS.
Similar articles
-
Examining theoretic models of adherence for validity in resource-limited settings. A heuristic approach.J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S18-22. doi: 10.1097/01.qai.0000248343.13062.4b. J Acquir Immune Defic Syndr. 2006. PMID: 17133200
-
Commentary on meta-analysis of randomized controlled trials for HIV treatment adherence interventions. Research directions and implications for practice.J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S36-40. doi: 10.1097/01.qai.0000248347.87512.ba. J Acquir Immune Defic Syndr. 2006. PMID: 17133203
-
HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice.J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S3-9. doi: 10.1097/01.qai.0000248333.44449.ea. J Acquir Immune Defic Syndr. 2006. PMID: 17133202
-
Adherence: a necessity for successful HIV combination therapy.AIDS. 1999;13 Suppl A:S271-8. AIDS. 1999. PMID: 10885784 Review.
-
Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence.Curr HIV/AIDS Rep. 2005 Nov;2(4):189-93. doi: 10.1007/s11904-005-0015-5. Curr HIV/AIDS Rep. 2005. PMID: 16343377 Review.
Cited by
-
Impact of an Asha intervention on depressive symptoms among rural women living with AIDS in India: comparison of the Asha-Life and Usual Care program.AIDS Educ Prev. 2012 Jun;24(3):280-93. doi: 10.1521/aeap.2012.24.3.280. AIDS Educ Prev. 2012. PMID: 22676466 Free PMC article. Clinical Trial.
-
Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations.BMC Infect Dis. 2019 Oct 29;19(1):913. doi: 10.1186/s12879-019-4443-z. BMC Infect Dis. 2019. PMID: 31664910 Free PMC article.
-
Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research.Curr HIV/AIDS Rep. 2008 Nov;5(4):186-92. doi: 10.1007/s11904-008-0027-z. Curr HIV/AIDS Rep. 2008. PMID: 18838058 Review.
-
Motivation as a Mechanism for Daily Experiences' Effects on HIV Medication Adherence.J Assoc Nurses AIDS Care. 2018 May-Jun;29(3):383-393. doi: 10.1016/j.jana.2017.09.003. Epub 2017 Sep 9. J Assoc Nurses AIDS Care. 2018. PMID: 28967490 Free PMC article.
-
Necessity and concerns beliefs and HIV medication adherence: a systematic review.J Behav Med. 2020 Feb;43(1):1-15. doi: 10.1007/s10865-019-00089-2. Epub 2019 Aug 8. J Behav Med. 2020. PMID: 31396819
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical